MULEVACLIN

Clinical Studies on a Multivalent Vaccine for Human Visceral Leishmaniasis

CoordinatorEtna Biotech (Italy) ; MEDITOX S.R.O ; AMVAC AG ; Autonomous University of Madrid ; Schweizerisches Tropen- und Public Health-Institut ; Infectious Disease Research Institute ; INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR-IBMC ; Istituto Superiore di Sanità ; Instituto de Salud Carlos III
Grant period2013-11-01 - 2018-10-31
Funding bodyEuropean Union
Call numberFP7-HEALTH-2013-INNOVATION-1
Grant number603181
IdentifierG:(EU-Grant)603181

     

Recent Publications

There are no publications


 Record created 2014-10-20, last modified 2023-02-28



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)